MBHB Partner Kevin Noonan discusses the ongoing efforts from the FTC and lawmakers to remove patent listings

In Bloomberg Law, MBHB Partner Kevin Noonan comments on the FTC’s approach to remove patents from the FDA’s Orange Book. View the article.